nk3201 has been researched along with Cardiovascular Stroke in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamoshita, K; Miyazaki, M; Sukenaga, Y; Takai, S | 1 |
| Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Sakaguchi, M; Sukenaga, Y; Takai, S; Yamada, M | 1 |
| Ikeda, T; Kanemitsu, H; Komeda, M; Miyazaki, M; Nishina, T; Takai, S; Tsuneyoshi, H; Yoshikawa, K | 1 |
1 review(s) available for nk3201 and Cardiovascular Stroke
| Article | Year |
|---|---|
Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities.
Topics: Acetamides; Animals; Chymases; Cricetinae; Myocardial Infarction; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Ventricular Remodeling | 2002 |
2 other study(ies) available for nk3201 and Cardiovascular Stroke
| Article | Year |
|---|---|
Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.
Topics: Acetamides; Animals; Cricetinae; Echocardiography, Doppler; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Pyrimidines; Renin; Serine Proteinase Inhibitors; Survival Rate | 2003 |
Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Topics: Acetamides; Algorithms; Animals; Body Weight; Chymases; Collagen Type I; Collagen Type III; Echocardiography; Fibrosis; Heart Diseases; Hemodynamics; Male; Myocardial Infarction; Myocardium; Organ Size; Protease Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Serine Endopeptidases; Transforming Growth Factor beta | 2006 |